Replies to post #218755 on Biotech Values

[DewDiligence]

Mavyret’s NRx% reached 49.0%—an all-time high—in the week ending 6/8/18, according to IMS, besting the old high of 47.6% (in the week ending 4/20/18).

Mavyret’s TRx% in the week ending 6/8/18, according to IMS, was 42.7%.